These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21179616)

  • 41. [Towards more efficient clinical trials for multiple system atrophy in Japan].
    Ichikawa Y
    Brain Nerve; 2012 Oct; 64(10):1141-9. PubMed ID: 23037604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic strategies in multiple system atrophy.
    Wenning GK; Geser F; Poewe W
    Mov Disord; 2005 Aug; 20 Suppl 12():S67-76. PubMed ID: 16092094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mouse model of adult-onset multiple system atrophy.
    Tanji K; Miki Y; Mori F; Nikaido Y; Narita H; Kakita A; Takahashi H; Wakabayashi K
    Neurobiol Dis; 2019 Jul; 127():339-349. PubMed ID: 30910745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.
    Wenning GK; Ben Shlomo Y; Magalhães M; Daniel SE; Quinn NP
    Brain; 1994 Aug; 117 ( Pt 4)():835-45. PubMed ID: 7922469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy.
    Valera E; Monzio Compagnoni G; Masliah E
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):95-106. PubMed ID: 26924723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?
    Ferini-Strambi L; Marelli S; Combi R
    Curr Neurol Neurosci Rep; 2016 Dec; 16(12):105. PubMed ID: 27844341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
    Jellinger KA
    Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR; Watson L; Mathias CJ
    Lancet; 1997 Jun; 349(9069):1877-81. PubMed ID: 9217760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current Treatment of Multiple System Atrophy.
    Maaß S; Levin J; Höglinger G
    Curr Treat Options Neurol; 2016 Dec; 18(12):51. PubMed ID: 27787721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation.
    Vieira BD; Radford RA; Chung RS; Guillemin GJ; Pountney DL
    Front Cell Neurosci; 2015; 9():437. PubMed ID: 26778958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple System Atrophy: Recent Developments and Future Perspectives.
    Meissner WG; Fernagut PO; Dehay B; Péran P; Traon AP; Foubert-Samier A; Lopez Cuina M; Bezard E; Tison F; Rascol O
    Mov Disord; 2019 Nov; 34(11):1629-1642. PubMed ID: 31692132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplantation of Adipose-Derived Stem Cells Alleviates Striatal Degeneration in a Transgenic Mouse Model for Multiple System Atrophy.
    Chang C; Liu JW; Chen BC; Jiang ZS; Tu CT; Su CH; Yang HH; Liu ZQ; Deng YC; Chen CY; Tsai ST; Lin SZ; Chiou TW
    Cell Transplant; 2020; 29():963689720960185. PubMed ID: 33028107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.
    Pavy-Le Traon A; Piedvache A; Perez-Lloret S; Calandra-Buonaura G; Cochen-De Cock V; Colosimo C; Cortelli P; Debs R; Duerr S; Fanciulli A; Foubert-Samier A; Gerdelat A; Gurevich T; Krismer F; Poewe W; Tison F; Tranchant C; Wenning G; Rascol O; Meissner WG;
    J Neurol Neurosurg Psychiatry; 2016 May; 87(5):554-61. PubMed ID: 25977316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple system atrophy: an update.
    Stefanova N; Bücke P; Duerr S; Wenning GK
    Lancet Neurol; 2009 Dec; 8(12):1172-8. PubMed ID: 19909915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features.
    Ishida C; Takahashi K; Kato-Motozaki Y; Tagami A; Komai K
    Intern Med; 2021 Feb; 60(3):367-372. PubMed ID: 32963152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence.
    Wenning GK; Tison F; Scherfler C; Puschban Z; Waldner R; Granata R; Ghorayeb I; Poewe W
    Cell Transplant; 2000; 9(2):279-88. PubMed ID: 10811400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple system atrophy: insights into a rare and debilitating movement disorder.
    Krismer F; Wenning GK
    Nat Rev Neurol; 2017 Apr; 13(4):232-243. PubMed ID: 28303913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus statement on the diagnosis of multiple system atrophy.
    Gilman S; Low PA; Quinn N; Albanese A; Ben-Shlomo Y; Fowler CJ; Kaufmann H; Klockgether T; Lang AE; Lantos PL; Litvan I; Mathias CJ; Oliver E; Robertson D; Schatz I; Wenning GK
    J Neurol Sci; 1999 Feb; 163(1):94-8. PubMed ID: 10223419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical changes in multiple system atrophy detected with positron emission tomography.
    Gilman S
    Parkinsonism Relat Disord; 2001 Jul; 7(3):253-256. PubMed ID: 11331195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.